PATENT CLAIM ANALYSIS

Application Number: 16019636
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["435", "235100"]

Abstract:
The invention in some aspects relates to recombinant adeno-associated viruses having distinct tissue targeting capabilities. In some aspects, the invention relates to gene transfer methods using the recombinant adeno-associate viruses. In some aspects, the invention relates to isolated AAV capsid proteins and isolated nucleic acids encoding the same.

Claim (Index 57):
A recombinant adeno-associated virus (rAAV) comprising an isolated nucleic acid encoding a heterologous transgene and the capsid protein of  claim 56 .

Metadata:
- Claim Count in Document: 17.0
- Percentile: 94.0
- Lexical Diversity: 1.60606
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13322164', '15007559', '14246560', '15520977', '15120294']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.729492513582351
- 35 USC 102 Novelty (BERT): 0.6985545769254063
- Combined Prediction Score: 0.7263987199166566
- Mean Citation Score: 617.305788
- Max Citation Score: 731.7288
- Similarity Product: 610.0479277293206

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test